Nuwellis (NUWE)
(Delayed Data from NSDQ)
$1.42 USD
+0.07 (5.19%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $1.40 -0.02 (-1.41%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Nuwellis, Inc. (NUWE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$17.00 | $17.00 | $17.00 | 1,159.26% |
Price Target
Only one analyst offered a short-term price target of $17.00 for Nuwellis, Inc. This represents an increase of 1% from the last closing price of $1.35.
Analyst Price Targets (1 )
Broker Rating
Nuwellis, Inc. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, one is Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/NUWE.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/29/2024 | Roth Capital Partners | Jonathan Aschoff | Not Available | Strong Buy |
5/3/2024 | Maxim Group | Anthony V Vendetti | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 2 |
Average Target Price | $16.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 73 of 253 |
Current Quarter EPS Est: | -0.88 |